LabCorp/$LH
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About LabCorp
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Ticker
$LH
Sector
Primary listing
NYSE
Employees
65,450
Headquarters
Website
LabCorp Metrics
BasicAdvanced
$21B
25.34
$10.19
0.87
$2.88
1.12%
Price and volume
Market cap
$21B
Beta
0.87
52-week high
$293.72
52-week low
$209.38
Average daily volume
851K
Dividend rate
$2.88
Financial strength
Current ratio
1.551
Quick ratio
1.089
Long term debt to equity
67.625
Total debt to equity
74.944
Dividend payout ratio (TTM)
28.24%
Interest coverage (TTM)
5.87%
Profitability
EBITDA (TTM)
1,963.5
Gross margin (TTM)
28.45%
Net profit margin (TTM)
6.21%
Operating margin (TTM)
9.92%
Effective tax rate (TTM)
22.19%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
4.63%
Return on equity (TTM)
10.14%
Valuation
Price to earnings (TTM)
25.338
Price to revenue (TTM)
1.565
Price to book
2.46
Price to tangible book (TTM)
-13.76
Price to free cash flow (TTM)
15.599
Free cash flow yield (TTM)
6.41%
Free cash flow per share (TTM)
16.546
Dividend yield (TTM)
1.12%
Forward dividend yield
1.12%
Growth
Revenue change (TTM)
8.28%
Earnings per share change (TTM)
98.36%
3-year revenue growth (CAGR)
1.95%
10-year revenue growth (CAGR)
5.88%
3-year earnings per share growth (CAGR)
-18.51%
10-year earnings per share growth (CAGR)
8.18%
3-year dividend per share growth (CAGR)
25.99%
What the Analysts think about LabCorp
Analyst ratings (Buy, Hold, Sell) for LabCorp stock.
LabCorp Financial Performance
Revenues and expenses
LabCorp Earnings Performance
Company profitability
LabCorp News
AllArticlesVideos
Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks
Business Wire·2 days ago
Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp
Business Wire·2 weeks ago
Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support
Benzinga·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LabCorp stock?
LabCorp (LH) has a market cap of $21B as of December 17, 2025.
What is the P/E ratio for LabCorp stock?
The price to earnings (P/E) ratio for LabCorp (LH) stock is 25.34 as of December 17, 2025.
Does LabCorp stock pay dividends?
Yes, the LabCorp (LH) stock pays dividends to shareholders. As of December 17, 2025, the dividend rate is $2.88 and the yield is 1.12%. LabCorp has a payout ratio of 28.24% on a trailing twelve-month basis.
When is the next LabCorp dividend payment date?
The next LabCorp (LH) dividend payment date is unconfirmed.
What is the beta indicator for LabCorp?
LabCorp (LH) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.